Article
4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.
British journal of clinical pharmacology - 1 Feb 2011
Diczfalusy Ulf, Nylén Hanna, Elander Pontus, Bertilsson Leif
Abstract excerpt
We have proposed that 4β-hydroxycholesterol (4β-OHC) may be used as an endogenous marker of CYP3A activity. The cholesterol metabolite 4β-OHC is formed by CYP3A4. Treatment of patients with strong inducers of CYP3A enzymes, e.g. anti-epileptic drugs, resulted in 10-fold increased concentrations of plasma 4β-OHC, while treatment with CYP3A inhibitors such as ritonavir or itraconazole resulted in decreased plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
